CAULI, ALBERTO
 Distribuzione geografica
Continente #
EU - Europa 194.570
NA - Nord America 9.212
AS - Asia 1.642
AF - Africa 32
OC - Oceania 26
SA - Sud America 24
Continente sconosciuto - Info sul continente non disponibili 3
Totale 205.509
Nazione #
IT - Italia 192.337
US - Stati Uniti d'America 9.136
CN - Cina 912
UA - Ucraina 735
SE - Svezia 541
SG - Singapore 345
DE - Germania 271
FI - Finlandia 239
GB - Regno Unito 183
VN - Vietnam 122
CA - Canada 74
FR - Francia 67
IN - India 45
JP - Giappone 38
NL - Olanda 36
HK - Hong Kong 34
KR - Corea 34
TR - Turchia 29
BE - Belgio 27
AU - Australia 23
IR - Iran 20
CZ - Repubblica Ceca 16
ES - Italia 16
IE - Irlanda 15
RU - Federazione Russa 15
PL - Polonia 14
BR - Brasile 13
IQ - Iraq 13
ID - Indonesia 12
EG - Egitto 11
LT - Lituania 10
IL - Israele 9
EC - Ecuador 7
AT - Austria 6
GR - Grecia 6
RO - Romania 6
TN - Tunisia 6
JO - Giordania 5
SI - Slovenia 5
TW - Taiwan 5
BD - Bangladesh 4
PH - Filippine 4
PT - Portogallo 4
BG - Bulgaria 3
BJ - Benin 3
CH - Svizzera 3
CI - Costa d'Avorio 3
HR - Croazia 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
RS - Serbia 3
DK - Danimarca 2
DZ - Algeria 2
EU - Europa 2
NO - Norvegia 2
PK - Pakistan 2
PS - Palestinian Territory 2
TH - Thailandia 2
A1 - Anonimo 1
AL - Albania 1
AR - Argentina 1
BN - Brunei Darussalam 1
CL - Cile 1
CM - Camerun 1
ET - Etiopia 1
KG - Kirghizistan 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
SA - Arabia Saudita 1
SC - Seychelles 1
SN - Senegal 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 205.509
Città #
Cagliari 185.192
Uta 6.408
Fairfield 1.219
Woodbridge 1.033
Boardman 675
Houston 654
Chandler 643
Ashburn 556
Wilmington 519
Ann Arbor 479
Seattle 440
Nyköping 405
Cambridge 393
Jacksonville 389
Dearborn 237
Singapore 179
Shanghai 156
Boston 143
Nanjing 141
Santa Clara 137
Dong Ket 118
Helsinki 118
Beijing 97
San Diego 91
Rome 75
Redwood City 62
Milan 55
Toronto 50
Shenyang 49
Guangzhou 45
Nanchang 45
London 40
Hebei 37
New York 37
Munich 36
Los Angeles 30
Mountain View 29
Jiaxing 27
Hong Kong 26
Phoenix 25
Tianjin 24
Changsha 22
Auburn Hills 21
Falls Church 21
Sassari 21
Seoul 21
Brussels 19
Hefei 19
Amsterdam 18
Norwalk 18
Orange 18
Washington 17
San Mateo 16
Pune 15
Ningbo 14
Tokyo 13
Verona 13
Dublin 12
Jinan 12
Naples 11
Turin 11
Wuhan 11
Chicago 10
Kunming 10
Leawood 10
Zhengzhou 10
Augusta 9
Brisbane 9
Detroit 9
Padova 9
Sivas 9
Brno 8
Paris 8
Ardabil 7
Baghdad 7
Borås 7
Guayaquil 7
Hounslow 7
Walnut 7
Buffalo 6
Hangzhou 6
Hyderabad 6
Indiana 6
Kiryat Ono 6
Laurel 6
Mumbai 6
Redmond 6
Selargius 6
Shenzhen 6
Taizhou 6
Amman 5
Bari 5
Duncan 5
Florence 5
Fuzhou 5
Istanbul 5
Kaunas 5
Kilburn 5
Nuoro 5
Sestu 5
Totale 201.716
Nome #
FRI0357 DRUG-INDUCED REMISSION AND SUBCLINICAL ACTIVITY IN PSORIATIC ARTHRITIS: TRANSCRIPTIONAL PROFILING TO CHARACTERIZE THE DISEASE STATE 10.637
Assessment Of Circulating Endothelial Cells And Their Progenitors As Potential Biomarkers Of Disease Activity And Damage Accrual In Behçet's Syndrome 3.042
Expression analysis of HLA-E and NKG2A and NKG2C receptors points at a role for natural killer function in ankylosing spondylitis 2.953
Physician's global assessment in psoriatic arthritis: A multicenter GRAPPA study 2.926
Gene expression profiling of monozygotic twins affected by psoriatic arthritis 2.917
Musculoskeletal manifestations as determinants of quality of life impairment in patients with systemic lupus erythematosus 2.805
Population-based analysis of hospitalizations for patients with systemic sclerosis in a West-European region over the period 2001–2012 2.719
AIF-1 gene does not confer susceptibility to Behçet's disease: Analysis of extended haplotypes in Sardinian population 2.699
Population-based analysis of hospitalizations in a West-European region revealed major changes in hospital utilization for patients with systemic lupus erythematosus over the period 2001-2012 2.678
Protective effects of hydroxychloroquine against accelerated atherosclerosis in systemic lupus erythematosus 2.541
Patient Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA and OMERACT Study 2.516
Demyelinating syndrome in SLE: review of different disease subtypes and report of a case series 2.504
Defective cerebral gamma-aminobutyric acid-A receptor density in patients with systemic lupus erythematosus and central nervous system involvement. An observational study 2.266
Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus 2.261
Prevalence and determinants of peripheral microvascular endothelial dysfunction in rheumatoid arthritis patients: a multicenter cross-sectional study 2.252
null 2.245
An allelic variant in the intergenic region between ERAP1 and ERAP2 correlates with an inverse expression of the two genes 2.216
Severe neuropsychiatric systemic lupus erythematosus successfully treated with rituximab: An alternative to standard of care 2.205
Molecular modifications induced by mud-bath therapy in patients with osteoarthritis 2.167
Polymyalgia rheumatica: an autoinflammatory disorder? 2.158
Spa therapy induces clinical improvement and protein changes in patients with chronic back pain 2.141
Demyelinating syndrome in SLE encompasses different subtypes: Do we need new classification criteria? Pooled results from systematic literature review and monocentric cohort analysis 2.119
PET/CT scan revealing active idiopathic inflammatory myopathy with normal serum sarcoplasmic enzymes levels 2.081
Killer-cell immunoglobulin-like receptors (KIR) and HLA-class I heavy chains in ankylosing spondylitis 2.078
Prognostic impact of coronary microcirculation abnormalities in systemic sclerosis: a prospective study to evaluate the role of non-invasive tests 2.057
Switch or swap strategy in rheumatoid arthritis patients failing TNF inhibitors? Results of a modified Italian Expert Consensus 2.030
The rs75862629 minor allele in the endoplasmic reticulum aminopeptidases intergenic region affects human leucocyte antigen B27 expression and protects from ankylosing spondylitis in Sardinia 2.028
Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis) 2.003
Predictors of flares in Systemic Lupus Erythematosus: Preventive therapeutic intervention based on serial anti-dsDNA antibodies assessment. Analysis of a monocentric cohort and literature review 1.998
Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: Systematic literature review and analysis of a monocentric cohort 1.944
The ankylosing spondylitis-associated HLA-B*2705 presents a B*0702-restricted EBV epitope and sustains the clonal amplification of cytotoxic T cells in patients 1.901
The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09 1.872
Re: Ultrasound Findings on Hands and Wrists of Patients with Systemic Lupus Erythematosus: Relationship with Physical Examination 1.853
Comment on: Auto-antibodies to double-stranded DNA as biomarker in systemic lupus erythematosus: comparison of different assays during quiescent and active disease 1.850
Pachidermoperiostosis as a cause of massive joint effusion with polyarticular involvement mimicking juvenile idiopathic arthritis: A case report 1.849
Ankylosing spondylitis: A trade off of HLA-B27, ERAP, and pathogen interconnections? Focus on Sardinia 1.849
Susceptibility to ankylosing spondylitis but not disease outcome is influenced by the level of HLA-B27 expression, which shows moderate variability over time 1.840
null 1.791
Rituximab treatment for 'rhupus syndrome': clinical and power-Doppler ultrasonographic monitoring of response. A longitudinal pilot study 1.700
Unusual Placement of an EBV Epitope into the Groove of the Ankylosing Spondylitis-Associated HLA-B27 Allele Allows CD8+ T Cell Activation 1.700
New approaches in tumor necrosis factor antagonism for the treatment of psoriatic arthritis: certolizumab pegol 1.591
null 1.562
ENDODONTIC RETREATMENT AS AN ALTERNATIVE TO SURGICAL THERAPY IN PATIENTS TREATED WITH BIPHOSPHONATES: A CASE REPORT 1.542
Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: the extension of the Psoriatic Arthritis Cost Evaluation (PACE) study 1.522
Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort study 1.494
Development and preliminary validation of the Behçet's syndrome Overall Damage Index (BODI) 1.486
null 1.431
Treatment target in newly diagnosed systemic lupus erythematosus: The association of lupus low disease activity state and remission with lower accrual of early damage 1.429
Active elderly and health—can moderate exercise improve health and wellbeing in older adults? Protocol for a randomized controlled trial 1.419
Recommendations for the use of biologics and other novel drugs in the treatment of psoriatic arthritis: 2017 update from the Italian Society of Rheumatology 1.387
Genetics of seronegative spondyloarthritis, susceptibility and aetiopathogenesis: A single centre experience 1.364
Joint and tendon involvement in systemic lupus erythematosus: an ultrasound study of hands and wrists in 108 patients 1.359
Accrual of organ damage in Behçet's syndrome: trajectory, associated factors, and impact on patients' quality of life over a 2-year prospective follow-up study 1.314
Use of Physician Global Assessment in systemic lupus erythematosus: a systematic review of its psychometric properties 1.296
Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients 1.226
Power Doppler ultrasonographic evaluation of enthesitis in psoriatic arthritis. A multi-center study 1.181
The growing role of cardiac magnetic resonance imagin in assessment and follow-up of pulmonary arterial hypertension associated with systemic sclerosis 1.179
Circulating CD8+CD28(null) T cytotoxic cells in polymyositis - a possible biomarker? Comment on the article by Pandya et al. 1.168
null 1.111
Targeted Therapies in Axial Psoriatic Arthritis 1.058
The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project) 1.043
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 1.030
Patient Assessments of Skin, Joint, and Nail Disease Activity in Psoriatic Arthritis Reply 1.016
Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis 994
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis 960
The adherence to ASAS classification criteria and to ASAS recommendations for the use of anti-TNF-alpha agents in axial spondyloarthritis 953
Molecular profiling of clinical remission in psoriatic arthritis reveals dysregulation of FOS and CCDC50 genes: a gene expression study 930
Updated guidelines for the management of axial disease in psoriatic arthritis 928
Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study 927
Hemarthrosis as acute presentation of acquired hemophilia in a patient with systemic lupus erythematosus: successful treatment and long-lasting remission 926
Proceedings of the GRAPPA 2016 retreat 909
null 902
Imbalanced MMP-3 and MMP-12 serum levels in systemic lupus erythematosus patients with Jaccoud's arthropathy and a distinctive MRI pattern 880
Effect of anti-P ribosomal and anti-NR2 antibodies on depression and cognitive processes in SLE: an integrated clinical and functional MRI study 845
Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus 844
HLA-B*2709 and lack of susceptibility to sacroiliitis: further support from the clinic 842
Psoriatic disease: Update on traditional disease-modifying antirheumatic drugs 841
Liver involvement in systemic lupus erythematosus: incidence, clinical course and outcome of lupus hepatitis 840
null 831
Two different clinical subsets of lupus hepatitis exist. Mimicking primary autoimmune liver diseases or part of their spectrum? 824
Corrigendum to: Exercise Improves the Impact of Chronic Pain in Older Adults: Results of an RCT 823
Coronary atherosclerosis using computed tomography coronary angiography in patients with systemic sclerosis: comment on the article by Mok et al 821
Telemedicine in rheumatology: high specificity and sensitivity of follow-up virtual video consultations during COVID-19 pandemic 797
Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review 794
Association of MICA alleles with psoriatic arthritis and its clinical forms. A multicenter Italian study 775
Familial chilblain and late contractural arachnodactyly: A novel association? 775
Whole-body MRI in rheumatology: Major advances and future perspectives 773
A functional polymorphism of the vasoactive intestinal peptide receptor 1 gene correlates with the presence of HLA-B*2705 in Sardinia 772
Patterns of Anti-Inflammatory and Immunomodulating Drug Usage and Microvascular Endothelial Function in Rheumatoid Arthritis 767
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 747
Genetics of psoriasis and psoriatic arthritis 737
Asymmetric dimethylarginine: A key player in the pathophysiology of endothelial dysfunction, vascular inflammation and atherosclerosis in rheumatoid arthritis? 723
Evaluation of cardiac functional abnormalities in systemic sclerosis by dobutamine stress echocardiography. A myocardial echostress scleroderma pattern 720
Discordance between patient and physician global assessment of disease activity in Behçet’s syndrome: a multicenter study cohort 711
Organ damage is a major determinant of work productivity impairment in Behçet's Syndrome: a post-hoc analysis of the BODI validation study 708
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 708
Psoriatic arthritis: genetics and pathogenesis 698
Development and implementation of the AIDA International Registry for patients with Behçet's disease 694
null 691
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS) 690
Totale 157.699
Categoria #
all - tutte 267.113
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 267.113


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202016.034 0 0 0 0 0 8.370 3.907 983 668 520 524 1.062
2020/202141.777 1.302 1.435 1.638 12.165 8.700 4.829 3.977 2.068 816 1.633 1.733 1.481
2021/202211.072 922 840 574 479 785 906 587 533 1.239 989 1.702 1.516
2022/202316.533 1.647 1.953 1.536 1.338 1.554 1.729 922 1.556 1.055 1.132 1.323 788
2023/202429.092 1.222 1.181 1.002 1.790 2.611 3.741 3.782 6.325 1.202 1.516 2.559 2.161
2024/202543.883 12.511 11.951 8.614 5.747 2.949 2.111 0 0 0 0 0 0
Totale 206.380